oral glp-1 analogues Trends in the Development of Receptor Agonists Peptide GLP-1 receptor agonists: From

In summary, a simple approach to modify and modulate the properties of bioactive peptide helices using small foldamer inserts was developed

This move follows encouraging Phase 2 results for AON and targets conditions with no approved neuroprotective treatments

131 , e142365 (2021)

Regular monitoring of albuminuria enables identification of patients most likely to benefit from specific reno-protective agents such as the SGLT2i, GLP-1RA or mineralocorticoid receptor antagonists mentioned above, and supports adjustment of treatment intensity to maximize benefit

Diabetes Care 43(5):10851093 Wilding JPH, Batterham RL, Calanna S et al (2021) Once-weekly semaglutide in adults with overweight or obesity